Evidence map›Paper›PMID 29073923›Full record

ArticleBMC research notes2017

Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol.

James Ditai, Laura J Frye, Jill Durocher, Meagan E Byrne, Sam Ononge, Beverly Winikoff, Andrew D Weeks

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

James DitaiSanyu Africa Research Institute (SAfRI), Mbale Regional Referral Hospital, P.O Box 2190, Mbale, Uganda.
Laura J FryeGynuity Health Projects, 15 East 26th Street, Suite 801, New York, NY, 10010, USA. LFrye@gynuity.org.
Jill DurocherGynuity Health Projects, 15 East 26th Street, Suite 801, New York, NY, 10010, USA.
Meagan E ByrneGynuity Health Projects, 15 East 26th Street, Suite 801, New York, NY, 10010, USA.
Sam OnongeDepartment of Obstetrics and Gynaecology, Makerere University College of Health Science, P.O Box 7072, Kampala, Uganda.
Beverly WinikoffGynuity Health Projects, 15 East 26th Street, Suite 801, New York, NY, 10010, USA.
Andrew D WeeksSanyu Research Unit, Department of Women's and Children's Health, University of Liverpool, Liverpool Women's' Hospital, Crown Street, Liverpool, L8 7SS, UK.
Gynuity Health Projects · USLiverpool Women's Hospital · GBMakerere University · UGUniversity of Liverpool · GB

Funding

Department of Health 16/16/06Department of Health HTA/16/16/06Department of Health II-LA-0712-20007Department of Health II-LA-0715-20008Medical Research Council MR/M017990/1
6 · The paper itself

Abstract

backgroundAdvance provision of misoprostol to women during antenatal care aims to achieve broader access to uterotonics for the prevention of postpartum hemorrhage. Studies of this community-based approach usually involve antenatal education as well as timely postpartum follow-up visits to confirm maternal and neonatal outcomes. The MamaMiso study in Mbale, Uganda sought to assess the feasibility of conducting follow-up visits in the postpartum period following advance provision of misoprostol for postpartum hemorrhage prevention. MamaMiso recruited women during antenatal care visits. Participants were asked to contact the research team within 48 h of giving birth so that postpartum follow-up visits could be carried out at their homes. Women's baseline and delivery characteristics were collected and analyzed with respect to follow-up time ('on time' ≤ 7 days, 'late' > 7 days, and 'lost to follow up'). Every woman who was followed up late due to a failure to report the delivery was asked for the underlying reasons for the delay. When attempts at following up participants were unsuccessful, a file note was generated explaining the details of the failure. We abstracted data and identified themes from these notes.

resultsOf 748 recruited women, 700 (94%) were successfully followed up during the study period, 465 (62%) within the first week postpartum. The median time to follow up was 4 days and was similar for women who delivered at home or in facilities and for women who had attended or unattended births. Women recruited at the urban hospital site (as opposed to rural health clinics) were more likely to be lost to follow up or followed up late. Of the women followed up late, 202 provided a reason. File notes explaining failed attempts at follow up were generated for 164 participants. Several themes emerged from qualitative analysis of these notes including phone difficulties, inaccurate baseline information, misperceptions, postpartum travel, and the condition of the mother and neonate.

conclusionsKeeping women connected to the health system in the postpartum period is feasible, though reaching them within the first week of their delivery is challenging. Understanding characteristics of women who are harder to reach can help tailor follow-up efforts and elucidate possible biases in postpartum study data. Trial Registration Number ISRCTN70408620 December 28, 2011.

Indexed as

AdultAftercareCommunity Health ServicesFemaleHome ChildbirthHumansMisoprostolOxytocicsPerinatal CarePostpartum HemorrhagePostpartum PeriodPrenatal CareUgandaYoung AdultMisoprostolOxytocicsBirthCommunity-basedFollow upMisoprostolPostpartum hemorrhageSelf-administrationUganda

Identifiers

PMID29073923
PMCPMC5658951
OpenAlexW2765357178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.